James Timothy Patrick Ryan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Mainz
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Humza Bokhari, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for James Timothy Patrick Ryan

Form 4 holding Chief Legal Officer and Chief Business Officer

BioNTech SE

Security class
Option (right to buy)
Shares / value
12,586
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Legal Officer and Chief Business Officer

BioNTech SE

Security class
Performance Share Unit
Shares / value
10,069
Estimated value
Report date
12 May 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Legal Officer and Chief Business Officer

BioNTech SE

Security class
Ordinary Shares
Shares / value
4,795
Estimated value
Report date
18 Mar 2026
Price
Ownership
Direct

Insider Reports Filed by James Timothy Patrick Ryan

3 BNTX

BioNTech SE

Report period
18 Mar 2026
Transactions
0
Transaction value
$0
Accepted by SEC
25 Mar 2026, 17:57
Role
Chief Legal Officer and Chief Business Officer; Exhibit List - Exhibit 24 - Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .